About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingPhase 1NCT05157802

Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia

Engage-Ataxia will implement a physical activity coaching program for people with cerebellar ataxia at Teachers College, Columbia University. This program expands upon the current Engage program for p...

Lead sponsor: Teachers College, Columbia University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Teachers College, Columbia University

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Neurologist confirmed diagnosis of cerebellar ataxia
•Scale for Ataxia Rating and Assessment (SARA) score between 8-25 (total score of 40), which will capture mild to moderate stage of the disease
•Ambulatory for indoor and outdoor mobility without assistance or assistive device
•Successful completion of Physical Activity Readiness Questionnaire (PAR-Q) or medical clearance from primary doctor
•Medical clearance to exercise

Exclusion Criteria

•Musculoskeletal injury that would prevent participation in an exercise program
•Other neurological disease or disorder such as stroke
•Cardiac/pulmonary conditions that would affect participants ability to participate exercise program
•Metabolic conditions that would affect participants during an exercise program
•Currently do moderate-vigorous exercise 5 days a week or more

Related studies

RECRUITINGPhase 1

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

NCT06672445 · Spinocerebellar Ataxia Type 2

RECRUITINGPhase 3

A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene

NCT07185347 · Spinocerebellar Ataxia 27B (SCA27B)

RECRUITINGPhase 1/2

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

NCT05822908 · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, and more

Enhancement of Quality of Work And Life

NCT06573866 · Parkinson Disease, Hereditary Spastic Paraparesis, and more

Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

NCT06633003 · Spinocerebellar Ataxia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 3, 2024Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE1

Enrollment30

Start dateMar 2021

Last updatedMay 3, 2024

Condition

Cerebellar Ataxia

Locations shown

Teachers College, Columbia University

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2024Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions